Quantcast

Latest Stem cell treatments Stories

2014-07-08 11:11:21

Journal of Neurosurgery Publishing Group A spinal mass was identified in a young woman with complete spinal cord injury 8 years after she had undergone implantation of olfactory mucosal cells in the hopes of regaining sensory and motor function. The case is reported and discussed in "Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient. Case report," by Brian J. Dlouhy, MD, Olatilewa Awe, MD, Rajesh C. Rao, MD, Patricia A....

Human Stem Cells Lead To Corneal Regrowth, Improved Vision In Mice
2014-07-03 08:25:39

Rebekah Eliason for redOrbit.com – Your Universe Online In an exciting new study, researchers have discovered a way to collect cells for the regeneration of corneal tissue – the clear membrane covering the pupil that directs light into the back of the eye. The research team from Boston reported that purified human stem cells were used to improve long-term vision in mice. Currently, the team is waiting for FDA-approval to begin patient clinical trials. This collaborative research...

2014-07-01 23:06:24

Medication and minimally invasive surgery to implant a sling can provide relief for millions of people who suffer from stress urinary incontinence (SUI), but not everyone responds to these therapeutic methods. A new study in the current STEM CELLS Translational Medicine tests the safety and effectiveness of stem cells as an alternative SUI treatment. Durham, NC (PRWEB) July 01, 2014 Medication and minimally invasive surgery to implant a sling can provide relief for millions of people who...

2014-07-01 11:00:54

HSC Mesenchymal stem cells have become attractive tools for bioengineers, but some scientists haven’t given up on their regenerative potential Stem cell scientists had what first appeared to be an easy win for regenerative medicine when they discovered mesenchymal stem cells several decades ago. These cells, found in the bone marrow, can give rise to bone, fat, and muscle tissue, and have been used in hundreds of clinical trials for tissue repair. Unfortunately, the results of these...

2014-06-30 08:31:42

GERMANTOWN, Md., June 30, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) reports that its shares have been added to the broad-market Russell 3000(®) Index. Annual reconstitution of Russell's U.S. indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization. Membership in the Russell 3000, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000(®) Index or small-cap Russell 2000(®) Index...

2014-06-25 12:30:18

HLI Co-Founder, Robert Hariri Speaks on Medical Innovation at 2014 BIO International Convention in San Diego LA JOLLA, Calif., June 25, 2014 /PRNewswire/ -- Human Longevity, Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, today called on physicians, the insurance industry and political leaders to support promising new avenues of medical discovery on behalf of patients with...

2014-06-25 08:30:00

Positions Company to Participate in One of the Fastest Growing Areas of Stem Cell Research LAS VEGAS, June 25, 2014 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company"), announced today the launch of a new service offering for the isolation and expansion of mesenchymal stem cells through its wholly owned subsidiary CorCell Companies, Inc. (CorCell). This service was researched and developed in CorCell's laboratory...

2014-06-25 04:20:56

GOSSELIES, Belgium, June 25, 2014 /PRNewswire/ -- Minimally invasive bone forming product ALLOB(R)in Phase I/IIa trial for delayed union fracture Bone Therapeutics, the regenerative therapy company addressing unmet medical needs in the field of bone diseases and orthopaedics, today announces that the first patient has been treated with its novel allogeneic osteoblastic (bone-forming) cell therapy product ALLOB(R) in its phase...

2014-06-19 08:30:26

GERMANTOWN, Md., June 19, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that select data from the NSI-189 Phase Ib trial in patients with major depressive disorder (MDD) will be presented at the International College of Neuropyschopharmacology (CINP) 2014 World Congress, in Vancouver, Canada. A poster entitled, "Effects of NSI-189, a neurogenic compound, on quantitative electroencephalography (qEEG) in patients with major depressive disorder (MDD) during a phase 1b...

2014-06-18 23:10:57

OMICS Group International is pleased to announce the 3rd International Conference and Exhibition on Cell & Gene Therapy to be held during October 27-29, 2014 in Las Vegas, USA. Cell Therapy conference takes the opportunity to explore the cell and magnify the therapeutization potential on the application grounds of genetic knowhow. Henderson, NV (PRWEB) June 18, 2014 Cell Therapy-2014 is a remarkable event which brings together research eminent from the expertise of cell and gene...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related